157 related articles for article (PubMed ID: 7790265)
21. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography.
Fujiwara T; Matsuzawa T; Kubota K; Abe Y; Itoh M; Fukuda H; Hatazawa J; Yoshioka S; Yamaguchi K; Ito K
J Nucl Med; 1989 Jan; 30(1):33-7. PubMed ID: 2536082
[TBL] [Abstract][Full Text] [Related]
22. Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET.
Buus S; Grau C; Munk OL; Rodell A; Jensen K; Mouridsen K; Keiding S
Radiother Oncol; 2006 Mar; 78(3):262-9. PubMed ID: 16545879
[TBL] [Abstract][Full Text] [Related]
23. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.
Rege SD; Chaiken L; Hoh CK; Choi Y; Lufkin R; Anzai Y; Juillard G; Maddahi J; Phelps ME; Hawkins RA
Radiology; 1993 Dec; 189(3):807-12. PubMed ID: 8234708
[TBL] [Abstract][Full Text] [Related]
24. L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate.
de Boer JR; Pruim J; van der Laan BF; Que TH; Willemsen AT; Albers FW; Vaalburg W
J Nucl Med; 2003 Mar; 44(3):341-6. PubMed ID: 12620998
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.
Eschmann SM; Paulsen F; Bedeshem C; Machulla HJ; Hehr T; Bamberg M; Bares R
Radiother Oncol; 2007 Jun; 83(3):406-10. PubMed ID: 17543402
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma.
Sjövall J; Wahlberg P; Almquist H; Kjellén E; Brun E
Head Neck; 2016 Apr; 38 Suppl 1():E473-9. PubMed ID: 25716933
[TBL] [Abstract][Full Text] [Related]
27. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?
Akagunduz OO; Savas R; Yalman D; Kocacelebi K; Esassolak M
Nucl Med Biol; 2015 Nov; 42(11):899-904. PubMed ID: 26275933
[TBL] [Abstract][Full Text] [Related]
28. Relationship between the uptake of
Watanabe Y; Kurihara H; Itami J; Sasaki R; Arai Y; Sugimura K
Radiat Oncol; 2017 Jan; 12(1):17. PubMed ID: 28088230
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
30. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients.
Bailet JW; Sercarz JA; Abemayor E; Anzai Y; Lufkin RB; Hoh CK
Laryngoscope; 1995 Feb; 105(2):135-9. PubMed ID: 8544591
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of
Hasebe M; Yoshikawa K; Nishii R; Kawaguchi K; Kamada T; Hamada Y
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1220-1228. PubMed ID: 28535963
[TBL] [Abstract][Full Text] [Related]
32. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Zundel MT; Michel MA; Schultz CJ; Maheshwari M; Wong SJ; Campbell BH; Massey BL; Blumin J; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e825-32. PubMed ID: 21300450
[TBL] [Abstract][Full Text] [Related]
33. Lung tumor imaging by positron emission tomography using C-11 L-methionine.
Kubota K; Matsuzawa T; Ito M; Ito K; Fujiwara T; Abe Y; Yoshioka S; Fukuda H; Hatazawa J; Iwata R
J Nucl Med; 1985 Jan; 26(1):37-42. PubMed ID: 2981300
[TBL] [Abstract][Full Text] [Related]
34. Metabolic imaging of ovarian tumors with carbon-11-methionine: a PET study.
Lapela M; Leskinen-Kallio S; Varpula M; Grénman S; Salmi T; Alanen K; Någren K; Lehikoinen P; Ruotsalainen U; Teräs M
J Nucl Med; 1995 Dec; 36(12):2196-200. PubMed ID: 8523104
[TBL] [Abstract][Full Text] [Related]
35. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation.
Garden AS; Weber RS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):619-26. PubMed ID: 7790247
[TBL] [Abstract][Full Text] [Related]
36. Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma.
de Boer JR; Pruim J; Albers FW; Burlage F; Vaalburg W; van der Laan BF
J Nucl Med; 2004 Dec; 45(12):2052-7. PubMed ID: 15585481
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Lin YC; Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Kao CH
J Nucl Med; 2015 Feb; 56(2):183-9. PubMed ID: 25613534
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study.
Kubota K; Yamada S; Ishiwata K; Ito M; Fujiwara T; Fukuda H; Tada M; Ido T
Eur J Nucl Med; 1993 Jun; 20(6):495-501. PubMed ID: 8393404
[TBL] [Abstract][Full Text] [Related]
39. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.
Lilja A; Lundqvist H; Olsson Y; Spännare B; Gullberg P; Långström B
Acta Radiol; 1989; 30(2):121-8. PubMed ID: 2493795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
